On Monday, Century Therapeutics Inc (NASDAQ: IPSC) was -7.19% drop from the session before settling in for the closing price of $0.51. A 52-week range for IPSC has been $0.51 – $4.43.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 27.56% over the last five years. When this article was written, the company’s average yearly earnings per share was at 26.23%. With a float of $38.84 million, this company’s outstanding shares have now reached $85.84 million.
The firm has a total of 150 workers. Let’s measure their productivity. In terms of profitability, gross margin is -51.52%, operating margin of -2108.03%, and the pretax margin is -1893.43%.
Century Therapeutics Inc (IPSC) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Century Therapeutics Inc stocks. The insider ownership of Century Therapeutics Inc is 54.86%, while institutional ownership is 34.94%. The most recent insider transaction that took place on Mar 10 ’25, was worth 1,375. In this transaction President and CEO of this company sold 2,235 shares at a rate of $0.61, taking the stock ownership to the 1,190,310 shares. Before that another transaction happened on Mar 10 ’25, when Company’s insider sold 2,360 for $0.61, making the entire transaction worth $1,451. This insider now owns 272,573 shares in total.
Century Therapeutics Inc (IPSC) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.23% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.80% during the next five years compared to 18.46% growth over the previous five years of trading.
Century Therapeutics Inc (NASDAQ: IPSC) Trading Performance Indicators
You can see what Century Therapeutics Inc (IPSC) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.62, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -1.30 in one year’s time.
Technical Analysis of Century Therapeutics Inc (IPSC)
Analysing the last 5-days average volume posted by the [Century Therapeutics Inc, IPSC], we can find that recorded value of 0.42 million was lower than the volume posted last year of 0.49 million. As of the previous 9 days, the stock’s Stochastic %D was 17.29%. Additionally, its Average True Range was 0.05.
During the past 100 days, Century Therapeutics Inc’s (IPSC) raw stochastic average was set at 0.44%, which indicates a significant decrease from 3.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 73.48% in the past 14 days, which was higher than the 71.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7002, while its 200-day Moving Average is $1.4583. Now, the first resistance to watch is $0.5007. This is followed by the second major resistance level at $0.5253. The third major resistance level sits at $0.5407. If the price goes on to break the first support level at $0.4607, it is likely to go to the next support level at $0.4453. Should the price break the second support level, the third support level stands at $0.4207.
Century Therapeutics Inc (NASDAQ: IPSC) Key Stats
There are 86,045K outstanding shares of the company, which has a market capitalization of 40.96 million. As of now, sales total 6,590 K while income totals -126,570 K. Its latest quarter income was 4,170 K while its last quarter net income were -36,070 K.
